Fundamental Valuation Report Aimmune Therapeutics(AIMT:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$25.48 (USD) 05/03/2019 Weighted Valuation$44.64 (USD) Overall RatingUndervalued by 75.2% Valuation Models Analyst Consensus: $54.00 (USD) (in …

Aimmune Therapeutics (AIMT:NAS) Fundamental Valuation Report Read more »

Read More

Fundamental Valuation Report Aimmune Therapeutics(AIMT:NAS) Healthcare:Biotechnology This Report was generated using the valuation tools available on StockCalc.com. For a free 30 day trial click here. –Close Price/Date$24.78 (USD) 04/03/2019 Weighted Valuation$44.46 (USD) Overall RatingUndervalued by 79.4% Valuation Models Analyst Consensus: $56.75 (USD) (in …

Aimmune Therapeutics (AIMT:NAS) Fundamental Valuation Report Read more »

Read More

Stockcalc – Free Trial Have a free look inside the StockCalc website at www.stockcalc.com I have used the analysis tools on the website stockcalc.com to generate some of the content of this blog post. These tools and reports are available …

Akers Biosciences (AKER:NAS) and Biostar Pharmaceuticals (BSPM:NAS) Are Biggest Stock Gainers YTD on NASDAQ Read more »

Read More